5-Nov-2025 5:30 AM CST - Business Wire Compass Pathways to Participate in Stifel 2025 Healthcare Conference $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the Stifel 2025 Healthcare Conference in New York, NY at 10:40 am ET on Tuesday, November 11, 2025. A live audio webcast of these events will be accessible from the Events page of the Investors section of the Compass website. A replay of the webcast will be ac
4-Nov-2025 5:30 AM CST - Business Wire Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the third quarter 2025 and provided an update on recent progress across its business. With the completion of COMP006 enrollment and our recent positive discussions with the FDA, we are excited about pulling forward our expected launch timing for COMP360 in TRD by 9-12 mon
28-Oct-2025 5:30 AM CST - Business Wire Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025 $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the third quarter ended September 30, 2025, and provide an update on recent developments, on November 4, 2025. Compass management will host a conference call at 8:00 am ET (1:00 pm UK) on November 4, 2025. A live webcast of the call will be available on t
27-Aug-2025 5:30 AM CST - Business Wire Compass Pathways to Participate in Four Investor Conferences in September $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the following September investor conferences: Cantor Global Healthcare Conference New York, NY: Fireside chat at 1:35 PM EST on September 3, 2025 Morgan Stanley 23rd Annual Global Healthcare Conference New York, NY: Fireside chat at 10:45 AM EST on September
31-Jul-2025 5:30 AM CST - Business Wire Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the second quarter 2025 and provided an update on recent progress across its business. With the recent positive 6-week primary endpoint from our first COMP360 Phase 3 study and the prior positive Phase 2b study, we have now delivered clinically meaningful and highly stati
22-Jul-2025 5:30 AM CST - Business Wire Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025 $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the second quarter ended June 30, 2025, and provide an update on recent developments, on July 31, 2025. Compass management will host a conference call at 8:00 am ET (1:00 pm UK) on July 31, 2025. A live webcast of the call will be available on the Compass
10-Jul-2025 3:00 PM CST - Business Wire Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in a fireside chat with Patrick Trucchio, Managing Director Equity Research at HC Wainwright at 8:00 am ET on July 14th, 2025. A live audio webcast of the presentation will be accessible from the Events page of the Investors section of the Compass website. A replay of the
14-May-2025 5:30 AM CST - Business Wire Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in a fireside chat at the 2025 RBC Capital Markets Global Healthcare Conference at 10:30 am ET on May 20th, 2025. A live audio webcast of the presentation will be accessible from the Events page of the Investors section of the Compass website. A replay of the web
8-May-2025 5:30 AM CST - Business Wire Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the first quarter 2025 and provided an update on recent progress across its business. We eagerly await the upcoming topline 6-week data readout, on track for late June, the first data from our pivotal phase 3 COMP360 program in treatment resistant depression. said Kabir
5-Nov-2025 5:30 AM CST - Business Wire Compass Pathways to Participate in Stifel 2025 Healthcare Conference $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the Stifel 2025 Healthcare Conference in New York, NY at 10:40 am ET on Tuesday, November 11, 2025. A live audio webcast of these events will be accessible from the Events page of the Investors section of the Compass website. A replay of the webcast will be ac
4-Nov-2025 5:30 AM CST - Business Wire Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the third quarter 2025 and provided an update on recent progress across its business. With the completion of COMP006 enrollment and our recent positive discussions with the FDA, we are excited about pulling forward our expected launch timing for COMP360 in TRD by 9-12 mon
28-Oct-2025 5:30 AM CST - Business Wire Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025 $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the third quarter ended September 30, 2025, and provide an update on recent developments, on November 4, 2025. Compass management will host a conference call at 8:00 am ET (1:00 pm UK) on November 4, 2025. A live webcast of the call will be available on t
27-Aug-2025 5:30 AM CST - Business Wire Compass Pathways to Participate in Four Investor Conferences in September $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the following September investor conferences: Cantor Global Healthcare Conference New York, NY: Fireside chat at 1:35 PM EST on September 3, 2025 Morgan Stanley 23rd Annual Global Healthcare Conference New York, NY: Fireside chat at 10:45 AM EST on September
31-Jul-2025 5:30 AM CST - Business Wire Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the second quarter 2025 and provided an update on recent progress across its business. With the recent positive 6-week primary endpoint from our first COMP360 Phase 3 study and the prior positive Phase 2b study, we have now delivered clinically meaningful and highly stati
22-Jul-2025 5:30 AM CST - Business Wire Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025 $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the second quarter ended June 30, 2025, and provide an update on recent developments, on July 31, 2025. Compass management will host a conference call at 8:00 am ET (1:00 pm UK) on July 31, 2025. A live webcast of the call will be available on the Compass
10-Jul-2025 3:00 PM CST - Business Wire Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in a fireside chat with Patrick Trucchio, Managing Director Equity Research at HC Wainwright at 8:00 am ET on July 14th, 2025. A live audio webcast of the presentation will be accessible from the Events page of the Investors section of the Compass website. A replay of the
14-May-2025 5:30 AM CST - Business Wire Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in a fireside chat at the 2025 RBC Capital Markets Global Healthcare Conference at 10:30 am ET on May 20th, 2025. A live audio webcast of the presentation will be accessible from the Events page of the Investors section of the Compass website. A replay of the web
8-May-2025 5:30 AM CST - Business Wire Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the first quarter 2025 and provided an update on recent progress across its business. We eagerly await the upcoming topline 6-week data readout, on track for late June, the first data from our pivotal phase 3 COMP360 program in treatment resistant depression. said Kabir
